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Summary
Presentation of antigen in the form of immune complexes to B lymphocytes by follicular dendritic
cells (FDC) is considered to be a central step in the generation of memory B cells. During this
process, which takes place in the microenvironment of the germinal center, B cells and FDC
are in close physical contact . In the present study, we have explored the molecular basis of FDC-B
cell interaction by using FDC and B cells derived from human tonsils. We found that FDC
express high levels of the adhesion receptors intercellular adhesion molecule 1(ICAM-1 [CD54])
and vascular cell adhesion molecule 1 (VCAM-1), while the B lymphocytes express lymphocyte
function-associated antigen 1 (LFA1 [CD11a/18]), very late antigen 4 (VLA-4 [CD49d], and
CD44. Furthermore, we established that both the LFA1/ICAM-1 and VLA-4/VCAM-1 adhesion
pathways are involved in FDC-B lymphocyte binding, and therefore, these pathways might be
essential in affinity selection of B cells and in the formation of B memory cells.
T
he germinal center forms a specialized microenvironment
that participates in the proliferation and differentiation
of B lymphocytes (1-3). The major constituents of germinal
centers are activated B lymphocytes and follicular dendritic
cells (FDC),' but some macrophages and T lymphocytes are
located there as well (4). The FDC is a large cell with elon-
gated cytoplasmic extensions that form the framework of the
germinal center (5). FDC present a major antigen-trapping
mechanism in the lymphoid tissues since they can bind an-
tigen, usually in the form of antigen-antibody complexes,
for long periods of time (6). Interactions between FDC and
B lymphocytes, which are intimately associated with the
ramifying processes of antigen-loaded FDC, are thought to
play an important role in the induction ofantibody synthesis,
affinity maturation of B cells, and memory B cell formation
(1-3, 7, 8). However, the molecular basis of FDC-B cell in-
teraction is at present largely unknown.
Three receptor families that are extensively involved in cell-
' Abbreviations used in this paper . ELAM-1, endothelial cell adhesion
molecule 1; FDC, folliculardendritic cell; ICAM-1, intercellular adhesion
molecule 1; LFA1, lymphocyte function-associated antigen 1; VCAM-1,
vascular cell adhesion molecule 1; VLA-4, very late antigen 4.
cell and cell-matrix binding in the immune system have been
described. These are the Ig family (9), the integrin family
(10-14), and the recently designated selectin family (15, 16).
Engagement of these receptors can transduce signals leading
to cellular events, while on the other hand, cytoplasmic signals
regulate the functional activity and cell surface expression of
these molecules (11, 12, 17-20). A wide variety ofadhesion-
dependent interactions of lymphocytes, both in antigen-
dependent and -independent processes, is mediated through
interaction of the integrin lymphocyte function-associated
antigen 1 (LFA-1) with the Ig superfamily member intercel-
lularadhesion molecule 1 (ICAM-1) (11, 12). These interac-
tions include CTIrmediated killing, T cell interaction with
APC, and lymphocyte binding to endothelium (11, 12, 21-26).
More recently, a novel adhesion pathway through very late
antigen 4 (VLA4) binding to vascular cell adhesion mole-
cule 1(VCAM-1) (27, 28) has been defined. These molecules
belong to, respectively, the integrin and Ig family, like LFA-1
and ICAM-1, and mediate lymphocyte and monocyte adhe-
sion to endothelium (29-32).
The typical reticular staining pattern observed in tissue sec-
tions of germinal centers stained with anti-ICAM-1(33) and
antiVCAM-1 mAbs (32) suggests the presence ofthese adhe-
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cules as ligands for lymphocyte binding to FDC. Indeed, re-
cently it was shown that isolated FDC express ICAM-1(34).
In the present study, we have explored the molecular basis
of FDC-B cell binding by analysis of adhesion receptor ex-
pression on isolated FDC and by studying FDC-B cell
clustering. The results show that both the LFA1/ICAM-1
and VLA-4/VCAM-1 pathways are involved in adhesion of
B cells to FDC.
Materials and Methods
Monoclonal Antibodies.
￿
The mAbs used were NKI-P2 (IgGl)
reactive with CD44 (35); CLB-LFA-1/1 (IgGl) and CLB-LFA-1/2
(IgGl) specific for the (3 and a subunits ofLFA-1, respectively (17);
W6/32 (IgG2a) specific for a nonpolymorphic determinant ofHLA-
ABC (36); F10.2 and RRl/1(IgGl) specific for ICAM-1(37); 2G7
(IgGl) and 4B9 (IgG1) specific for VCAM-1 (30, 31); 7A9 (IgGl)
specific for ELAM-1(31), HPl/3 (IgG3) and HP2/1(IgGl) specific
for the a subunit of VLAA (38); CLB-CD2 (IgGl); CLB-CD3
(IgGl); CLB-CD45 (IgGl) (CLB,Amsterdam, The Netherlands);
and DRC-1 (IgM) reactive with FDC (39).
FDC Isolation.
￿
FDC were isolated as described previously (40,
41). In brief, freshly obtained tonsillar tissue was dissected free from
surface epithelium, and cubes (1 mm') of lymphoid tissue were
incubated under continuous rotation for 30 min at room tempera-
ture in Opti-MEM (Gibco Laboratories, Paisley, UK) containing
15 U/mlcollagenase (typeXI; Sigma Chemical Co., St. Louis, MO),
0.025 U/ml DNAse (Boehringer, Ingelheim, FRG), 0.5% BSA
(RIA grade; Sigma Chemical Co.). Next, the cells were centrifuged
for 10 min at 600 g. The pellet was resuspended in Opti-MEM,
and subjected to 1 g sedimentation (30 min, 0°C) in a discontinuous
BSA gradient consisting of layers of 1.5, 2.5, 5.0, and 7.5% BSA.
Cells in the interphase between 2.5 and 5% BSA were collected,
and layered on a Percoll (Pharmacia Fine Chemicals, Uppsala,
Sweden) gradient consisting of layers with densities of1.070, 1.060,
and 1.030, and centrifuged for 20 min at 1,200g. Cells with densi-
ties of 1.030 and 1.060 were collected. This procedure yielded be-
tween 5 x 106 and 2 x 10' cells per tonsil. The isolated cell
population contained -30% FDC identified as DRCl-positive,
largebinucleated cells with dendritic processes. The contaminating
cells consisted almost entirely of B cells (CD19*) and a few T cells
(CD3 *).
FDC-B Cell Adhesion Assay.
￿
Isolated FDC preparations were
seeded in 96-well flat-bottomed microtiter plates. Per well, 2 x
101 cells in 100 pl Hepes-buffered RPMI 1640 (Gibco Laborato-
ries) containing 10% FCS (HyClone Laboratories, Inc., Logan, UT)
were incubated for various times at 37°C in the absence or pres-
ence of mAbs. All mAbs were titrated to give optimal inhibitory
effects. The bivalent cation requirement was studied by washing
the cells in HBSS without calcium and magnesium (Gibco Labora-
tories) containing 2 mg/ml D-glucose. Next, the cells were plated
and 1 mM calcium chloride (Merck, Darmstadt, FRG) or 1 mM
Magnesium chloride (Merck) was added. The metabolic require-
ments for adhesion were studied by adding 0.1% sodium azide
(Merck) in combination with 50 mM 2-deoxy-D-glucose (Aldrich
Chemical Co., Inc., Milwaukee, WI) to the wells.
FDC-B cell adhesion was measured in a semiquantitative manner,
analogous to the method described by Rothlein et al. (37) for quan-
tifying homotypic cell aggregation. This method was modified to
express adequately the amount of FDC-B cell clustering. Adhe-
sion was scored as: 0, no cell aggregation observed; 1, <20% of
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the B cells formed small clusters with FDC; 2, 20-50% of the
B cells formed clusters with FDC; 3, 50-80% of the B cells were
found in FDC clusters; 4, >80% ofthe B cells were found in FDC
clusters; 5, >90% of the cells were found in large FDC clusters.
Immunohistochemistry.
￿
A two-step immunoperoxidase staining
was performed on acetone-fixed cryostat sections of tonsils and
lymph nodes, as described previously (35). All antibodies were
diluted to give optimal staining results. The second-step antibody,
a horseradish peroxidase-conjugated rabbit'anti-mouse IgG an-
tiserum (DAKO, Glostrup, Denmark) contained 5% normal human
serum. Sections were routinely counterstained with haematoxylin.
Detection of adhesion molecules on isolated FDC was performed
by immunofluorescence double staining on acetone-fixed cytocen-
trifuge preparations ofisolated FDC. Slides were pre-incubated for
10 min with 10% human pool serum diluted in PBS/BSA (1%).
Subsequently, the preparations were incubated for 30 min with the
mAbs listed in Table 1, washed, and incubated with 1:20 diluted
goat anti-mouse IgG-1 FITC (Southern Biotechnology, Inc., Bir-
mingham, AL); followed by 1:5 dilutedDRCI antibody (DAKO),
and with 1:100 diluted tetramethyl rhodamine iso-thio-cyanate
(TRITC)-conjugated goat anti-mouse IgM (Southern Biotech-
nology, Inc.).
Results
Expression ofAdhesion Receptors on FDC
￿
In accordance
with previous reports (32, 33), immunoperoxidase staining
of cryostat sections of human tonsils and lymph nodes with
anti-ICAM-1 and antiVCAM-1 mAbs yielded a typical re-
ticular staining of the germinal centers, which suggested the
expression of both molecules on FDC. This staining pattern
was not observed with mAbs against the other adhesion
receptors studied, i.e., with anti-LFA-1, VLA-4, C1344, and
endothelial cell adhesion molecule 1(ELAM-1), which stained
variable combinations of lymphocytes, macrophages, and en-
dothelial cells (data not shown) .
To discriminate more rigorously between FDC staining
and staining of germinal center lymphocytes, cytocentrifuge
preparations of tonsillar FDC isolates were double stained
with the FDC-specific mAb DRC1 and mAbs against the
above-mentioned adhesion receptors, using a combination of
FITC- and TRITC-conjugated isotype-specific second-step
antibodies. The FDC isolates contained -30% FDC, i.e.,
large DRC1-positive cells (Fig. 1 A), while the coisolated
cells consisted largely (>90%) of B lymphocytes (CD19*)
with a few intermingled T lymphocytes (CD3* ). Of the
coisolated B lymphocytes, 10% had small condensed nuclei
(probably unstimulated B cells). The other 90% of the cells
showed a great variability in size and nuclear morphology,
consistent with germinal center B cells. 50-60% of these B
cells were PNA positive, and 70-80% were IgD negative.
Thus, a large proportion of the coisolated B cells had the
characteristics of germinal center B cells.
Immunofluoresence double staining showed that isolated
FDC expressed both VCAM-1 and ICAM-1 (Fig. 1, B and
C; Table 1) and were negative for LFA-1 (Fig. 1 D; Table
1), VLA-4, ELAM-1, and CD44 (Table 1). The coisolated
B lymphocytes, on the other hand, expressed LFA1, CD44,
and low levels of VLA-4, but were VCAM-1, ICAM-1, and
ELAM-1 negative (Table 1).Figure 1 .
￿
Expression ofadhesion molecules onFDC. Cytocentrifuge preparations of isolated FDC were haematoxilin-eosin stained (A, left) or stained
for DRC1 using immunoperoxidase (A, right), or double stained forDRC1 and ICAM-1 (B), VCAM-1 (C), or LFA-1 (D) using immunofluorescence.
DRCI is labeled red (anti-mouse IgMTRITC), while ICAM-1, VCAM-1, and LFA-1 are labeled green (anti-mouse IgGl-FITC) (x350) .
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￿
FDC-B lymphocyte adhesion assay. FDC and coisolated B lymphocytes were plated in microtiter plates at 2 x 105 cells per well. Adhe-
sion between B cells and FDC was scored semiquantitatively on a scale ranging from 0 to 5 . Typical adhesion patterns scored as 0 (A), 1 (B), 2 (C),
3 (D), 4 (E), and 5 (F) are shown (x200) . Adhesion patterns 0, 1, 2, and 3 were recorded during a 3-h adhesion experiment without addition of
mAbs. Adhesion patterns 4 and 5 were only observed after incubation with anti-CD44 for 3 and 24 h, respectively.
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￿
Expression of Adhesion Molecules and
Surface Antigens on FDC and Coisolated B Cells
- , negative;
￿
+ , weak; + + , strong.
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FDC-B Lymphocyte Adhesion.
￿
When the FDC isolates
were kept at 4°C, no cell cluster formation occurred between
the FDC and the coisolated B lymphocytes (Fig. 2 A). How-
ever, upon incubation at 37°C, progressive spontaneous
FDC-B cell clustering was observed. This cluster formation
reached its maximum within 2-3 h of incubation. The var-
ious phases of this clustering process were scored semiquan-
titatively on a scale from 0 to 5. Typical patterns are shown
in Fig. 2. In the presence of sodium azide and 2-deoxy-D-
glucose, which like low temperature (4°C) interferes with
metabolic energy-dependent processes, no FDC-B cell adhe-
sion occurred. Furthermore, FDC-B cell clustering required
divalent cations since no conjugate formation was observed
in the absence of calcium and magnesium. Cluster forma-
Medium
CD45
LFA-la
LFA-la
VLA-4a
LFA-la + VLA-4a
ICAM-1
vCAM-1
ICAM-1 + vCAM-1
VLA-4a + VCAM-1
Figure 4.
￿
Inhibition ofFDC-B lymphocyte adhesion by combinations
ofmAbs. Cluster formation was measured after 3 h in the absence or pres-
ence of mAbs against adhesion molecules alone or in combinations as in-
dicated. Except in results marked (') where anti-LFA-Ia was added in
a suboptimal noninhibitory concentration (ascites, 1:105), all mAbs were
added in concentrations to give optimal inhibition. A representative ex-
periment is shown.
tion was largely restored by magnesium, however, not by cal-
cium (data not shown) .
Adhesion Receptors Involved in FDC-B CellAggregation.
￿
To
determine the adhesion pathway(s) involved in FDC-B cell
binding, mAb inhibition studies were performed. mAbs
against LFA-la and LFA-1# blocked FDC-B cell adhesion
completely (Fig. 3) . Antibodies against ICAM-1 (F10.2 and
RRl/1), a major ligand ofLFA-1, also inhibited FDC-B cell
CD44
Control
VCAM-1
VLA-4
ICAM-1
Figure 3.
￿
mAb inhibition studies of FDC-B lym-
phocyte adhesion. Cluster formation was measured in
the absence or presence ofmAb against the indicated
adhesion receptors. mAbs used were NKI-P2 (anti-
CD44); 2G7 (anti-VCAM-1); HP1/3 (antiVLA-4a);
F10.2 (anti-ICAM-1); CLB-LFAI/1 (anti-LFA1,8); and
CLB-LFAl/2 (LEA-lot). All mAbs wereadded in con-
centrations to give optimal inhibitory effect. mAbs
CLB-CD45 (anti-CD45), CLB-CD2 (anti-CD2), and
FA -1a
￿
W6/32 (anti-HLA-ABC) were usedas additional con-
trols and gave no inhibitory effect. Shown the mean
± SE of three independent experiments.
Antigen FDC B cell
LFA-1(3 (CD18) - + +
LFA-la (CD11a) - + +
VLA-4cY (CD49d) - +
ICAM-1 (CD54) + +
VCAM-1 + +
CD44 -
ELAM-1 -
CD19 - + +
CD45 - + +
HLA-ABC + + +
DRC-I + + -
CD3 - -adhesion, although inhibition by these mAbs was incomplete
(Fig. 3). In addition to mAbs interfering with the LFA-1/
ICAM-1 pathway, mAbs HP2/1 and HPl/3 against VLA-4,
and mAbs 2G7 and 4B9 against its ligand VCAM-1, also in-
hibited FDC-B cell aggregation, although inhibition by these
mAbs was incomplete (Fig. 3). Together, these results indi-
cated that both the LFA-1/ICAM-1 and VLA-4/VCAM-1
pathways were involved in FDC-B cell adhesion. A series
of experiments combining antibodies interfering with the
LFA-1/ICAM-1 and VLA4/VCAM-1 pathways further
strengthens this conclusion (Fig. 4) . Thus, the level of inhi-
bition ofFDC-B cell clustering was consistently higher with
anti-ICAM-1 in combination with antiVCAM-1 than with
either of the antibodies alone, while the inhibitory effects
of antiVCAM-1 and antiVLA4 were not additive. Anti-
VLA-4 antibodies in combination with suboptimal (nonin-
hibitory) concentrations of anti-LFA-la caused strong addi-
tive blocking of FDC-B cell adhesion (Fig. 4) .
In contrast to mAbs against molecules involved in the LFA
1/ICAM-1 and VLA4/VCAM-1 pathways, antibodies against
CD44 enhanced FDC-B cell clustering (Fig. 3). Like the spon-
taneous aggregation ofFDC and B cells, this induced aggre-
gation could be inhibited with anti-LFA-1 mAb (data not
shown). Antibodies against CD2, CD45, HLAABC, and
ELAM-1 did not affect FDC-B cell adhesion (Fig. 4).
Discussion
Presentation of antigen in the form of immune complexes
to B lymphocytes by FDC is thought to be a central step
in affinity selection of B cells and in B cell differentiation
into memory cells (1-3). The intimate spatial relationship
between FDC and B cells, as found in germinal centers (1,
5), suggests that initiation of these differentiation steps re-
quires direct FDC-B cell contact. Our present data show that
conjugate formation between isolated FDC and B cells de-
pends on at least two different adhesion pathways, i.e., the
LFA-1/ICAM-1 and the VLA4/VCAM-1 pathway. This
finding suggests that, in parallel with the requirements for
efficient antigen presentation to T cells by macrophages/den-
dritic cells (11, 12, 21-24), antigen presentation to B cells
by FDC also is not only depend on antigen-specific receptor
interactions but on engagement of adhesion receptors as well.
These adhesion molecules may help to establish and main-
tain direct physical contact during interaction of FDC and
B cells.
Determination ofthe antigenic profile of isolated FDC re-
vealed that these cells express high levels of ICAM-1 and
VCAM-1 (Fig. 1, Table 1); in contrast, those antigens were
not detectable on the coisolated B lymphocytes. On the other
hand, LFA1, VLA4ot, and CD44 were present on the B cells
but absent from FDC (Fig. 1, Table 1). These findings sug-
gested that the leucocyte integrins LFA-1 and VLA4 might
both be involved in B cell-FDC binding, since both their
ligands, i.e., ICAM-1 and VCAM-1, were present on the FDC.
In addition, the metabolic energy and divalent cation depen-
dence of the FDC-B cell interaction was consistent with a
role of integrins. Indeed, the results of our blocking studies
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showed that clustering of FDC and B lymphocytes involves
both the LFA1/ICAM-1 and VLA4/VCAM-1 pathways (Fig.
3). Antibodies against LFA-1 strongly inhibited conjugate
formation of FDC and B cells, while antibodies against the
LFA-1 ligand ICAM-1 also inhibited FDC-B lymphocyte
interaction, although these antibodies were less effective.
Whether this difference in blocking between LFA1 and
ICAM-1 relates to factors such as antibody avidity or reflects
involvement of an additional ligand for LFA-1, possibly
ICAM-2 (42), is presently unknown. As expected, blocking
via the LFA-1/ICAM-1 and VLA-4/VCAM-1 pathways was
additive (Fig. 4), a finding that confirms the independent con-
tribution of the two adhesion pathways to the process of
FDC-B cell aggregation.
Our present findings greatly extend recent data by Freedman
et al.'(43). These authors showed that activated B cells bind
preferentially to germinal centers in frozen sections ofhuman
tonsils. Furthermore, they showed that binding of a cell line
(Nalm-6) to germinal centers was completely blocked by anti-
VLA4 and antiVCAM-1 antibodies. Although this interac-
tion was suggested to involve binding to FDC in the ger-
minal centers, no direct evidence for involvement of FDC
was provided. Moreover, the study of Freedman et al. (43)
did not reveal a role of LFA1/ICAM-1 in lymphocyte binding
to germinal centers, while our present study indicates that
the LFA1/ICAM-1 pathway is at least as important in FDC-B
cell binding as the VLA-4/VCAM-1 pathway. A putative ex-
planation for this discrepancy is that LFA1 expression per
se is not sufficient for effective FDC binding, but that other
factors, e.g., other molecules or the stateofactivation ofLFA-1
(12, 19, 20, 22), could also be important. Since Freedman
et al. (43) studied a limited number of cell lines, of which
only two were LFA-1 positive, these requirements may not
have been met.
Our finding that at least two different pathways partici-
pate in binding of B lymphocytes to FDC is consistent with
many other studies of lymphocyte-cell interaction, which have
almost invariably demonstrated involvement ofseveral, some-
times multiple, interaction pathways (11, 12, 15, 17, 18, 21,
44). For instance, CTL require not only the TCR-CD3 com-
plex and the CD8 molecule to interact with their target cells,
but also binding of LFA-1 to ICAM-1 and of CD2 to LFA-3
(11, 12, 21). Similarly, lymphocyte extravasation at sites of
inflammation and lymphocyte recirculation are mediated
through a series of interactions between cell surface mole-
cules on lymphocytes and endothelial cells. Receptors and
ligands involved are LFA-1/ICAM-1 (15, 25, 26, 44), VLA-
4/VCAM-1 (27-32), LAM-1 (LECAM-1, MELr14) (15, 26,
44, 45), and CD44 (44, 45, 46). The fact that multiple
receptors are engaged in these lymphocyte interactions does
not only allow for sophisticated fine-tuning of these interac-
tions, but, in addition, may have an important back-up func-
tion. This latter point is illustrated by the fact that patients
with leucocyte adhesion deficiency, which lack expression of
LFA1, show relatively little evidence of lymphocyte dysfunc-
tion (46-48).
In marked contrast to the inhibitory effects of anti-LFA-1,
ICAM-1, VLA-4, and VCAM-1 mAbs, anti-CD44 mAbspromoted FDC-B lymphocyte cluster formation. This anti-
CD44-promoted adhesion was completely blocked by anti-
LFA1 mAbs, suggesting that triggering of CD44 molecules
can enhance LFA-1-mediated FDC-B cell adhesion, similar
to the CD44-induced homotypic T cell aggregation (49).
However, further studies are needed to confirm this notion
since CD44 can also mediate adhesion via binding to hyal-
uronate (46, 50, 51).
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